Avantor, Inc. Stock

Equities

AVTR

US05352A1007

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-04-19 pm EDT 5-day change 1st Jan Change
24.1 USD -0.82% Intraday chart for Avantor, Inc. -3.45% +5.56%
Sales 2024 * 6.97B Sales 2025 * 7.35B Capitalization 16.37B
Net income 2024 * 457M Net income 2025 * 631M EV / Sales 2024 * 3.02 x
Net Debt 2024 * 4.7B Net Debt 2025 * 3.94B EV / Sales 2025 * 2.76 x
P/E ratio 2024 *
33.3 x
P/E ratio 2025 *
25 x
Employees 14,500
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.69%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 51 14-04-30
Director of Finance/CFO 54 23-08-06
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 54 21-10-31
Director/Board Member 68 20-05-06
Chairman 66 17-03-31
More insiders
Date Price Change Volume
24-04-19 24.1 -0.82% 4,712,589
24-04-18 24.3 -0.33% 4,195,951
24-04-17 24.38 -0.89% 5,696,340
24-04-16 24.6 -0.45% 2,586,182
24-04-15 24.71 -1.00% 2,399,982

Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT

More quotes
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies & applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
24.3 USD
Average target price
27.85 USD
Spread / Average Target
+14.62%
Consensus